| Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer. | |
| Zhou Danmei; Ren Kehan; Wang Jigang; Ren Hong; Yang Wenlin; Wang Wenjuan; Li Qiong; Liu Xiuping; Tang Feng | |
| 刊名 | Oncology letters
 |
| 2018 | |
| 卷号 | 15期号:4 |
| 关键词 | breast cancer erythropoietin-producing hepatocellular A6 estrogen receptor human epidermal growth factor receptor 2 progesterone receptor prognosis |
| ISSN号 | 1792-1074 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3606001 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Zhou Danmei,Ren Kehan,Wang Jigang,et al. Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.[J]. Oncology letters,2018,15(4). |
| APA | Zhou Danmei.,Ren Kehan.,Wang Jigang.,Ren Hong.,Yang Wenlin.,...&Tang Feng.(2018).Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer..Oncology letters,15(4). |
| MLA | Zhou Danmei,et al."Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.".Oncology letters 15.4(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论